Privium Fund Management B.V. Axsome Therapeutics, Inc. Transaction History
Privium Fund Management B.V.
- $354 Million
- Q2 2024
A detailed history of Privium Fund Management B.V. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Privium Fund Management B.V. holds 74,332 shares of AXSM stock, worth $6.72 Million. This represents 1.69% of its overall portfolio holdings.
Number of Shares
74,332
Previous 82,032
9.39%
Holding current value
$6.72 Million
Previous $6.55 Million
8.6%
% of portfolio
1.69%
Previous 1.94%
Shares
4 transactions
Others Institutions Holding AXSM
# of Institutions
289Shares Held
40.4MCall Options Held
365KPut Options Held
428K-
Rtw Investments, LP New York, NY4.63MShares$419 Million6.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$338 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$298 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$213 Million37.71% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.85MShares$167 Million4.89% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.87B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...